Overview

To Evaluate the Effect of Single Oral Dose of MY008211A Tablets on QTc Interval in Healthy Subjects

Status:
NOT_YET_RECRUITING
Trial end date:
2024-12-13
Target enrollment:
Participant gender:
Summary
A Concentration-QT Interval Correction (C-QTc) study of MY008211A Tablets in Healthy Subjects
Phase:
PHASE1
Details
Lead Sponsor:
Wuhan Createrna Science and Technology Co., Ltd